(FM) Oncología
Departamento académico
Washington University in St. Louis School of Medicine
San Luis, Estados UnidosPublicacions en col·laboració amb investigadors/es de Washington University in St. Louis School of Medicine (7)
2022
-
Nivolumab plus rucaparib for metastatic castration-resistant prostate cancer: results from the phase 2 CheckMate 9KD trial
Journal for immunotherapy of cancer, Vol. 10, Núm. 8
2021
-
Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study
The Lancet Diabetes and Endocrinology, Vol. 9, Núm. 8, pp. 491-501
2020
-
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
Nature Medicine, Vol. 26, Núm. 6, pp. 878-885
2016
-
Factors Associated with Early Mortality in Patients Treated with Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer
International Journal of Radiation Oncology Biology Physics, Vol. 94, Núm. 3, pp. 612-620
2015
-
Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small-cell lung cancer beneficial? A multi-institutional propensity score matched analysis
International Journal of Radiation Oncology Biology Physics, Vol. 91, Núm. 1, pp. 133-139
2013
-
Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: An individual patient data meta-analysis
International Journal of Radiation Oncology Biology Physics, Vol. 87, Núm. 4, pp. 690-696
-
Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: An international individual patient data meta-analysis
International Journal of Radiation Oncology Biology Physics, Vol. 85, Núm. 2, pp. 444-450